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controls (6.3 [2] vs. 3.9 [1.9] ng/mg Cholesterol; p = 0.004). 24S-HC
and 27-HC levels were respectively ﬁve and 20-fold higher in the
arterial tissue of PAD individuals than in those of the controls
(p = 0.016 and p = 0.001). Plasma C-reactive protein correlated
with plasma 24S-HC (r = 0.51; p = 0.010), 25-HC (r = 0.75;
p b 0.001), 27-HC (r = 0.48; p = 0.015), and with tissue 24S-HC
(r = 0.40; p = 0.041) and 27-HC (r = 0.46; p = 0.023). Conclusion:
The accumulation in the arterial intima of oxysterols originated
enzymatically, and not by the action of free radicals, is associated
with the severity of atherosclerotic disease and of the systemic
inﬂammatory activity in individuals with severe PAD.
doi:10.1016/j.bbacli.2015.05.036
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Background: Misclassiﬁcation of patients as low cardiovascular
risk (LCR) remains a major concern and challenges the efﬁcacy of
traditional risk markers. Due to its strong association with choles-
terol acceptor capacity, high-density lipoprotein (HDL) size has been
appointed as a potential risk marker. Hence, we investigate whether
HDL size improves the predictive value of HDL-cholesterol in the
identiﬁcation of carotid atherosclerotic burden in individuals strat-
iﬁed to be at LCR. Methods: 284 individuals (40–75 years) classiﬁed
as LCR by the current US guidelines were selected in a three-step
procedure from primary care centers of the cities of Campinas and
Americana, SP, Brazil. Apolipoprotein B-containing lipoproteins were
precipitated by polyethylene glycol and HDL size was measured by
dynamic light scattering (DLS) technique. Participants were classiﬁed
in tertiles of HDL size (b7.57; 7.57–8.22; N8.22 nm). Carotid intima–
media thickness (cIMT) b0.90 mm (80th percentile) was determined
by high resolution ultrasonography and multivariate ordinal regres-
sion models were used to assess the association between cIMT across
HDL size and levels of lipid parameters. Results: HDL-cholesterol was
not associated with cIMT. In contrast, HDL size N8.22 nm was
independently associated with low cIMT in either unadjusted and
adjusted models for age, gender and Homeostasis Model Assessment
2 index for insulin sensitivity, ethnicity and body mass index (odds
ratio 0.23; 95% conﬁdence interval 0.07–0.74, p = 0.013). Conclu-
sion: The mean HDL size estimated with DLS constitutes a better
predictor for subclinical carotid atherosclerosis than the convention-
al measurements of plasma HDL-cholesterol in individuals classiﬁed
as LCR.
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Introduction: In this study, ALA gold nanoparticles (ALA:AuNPs)
functionalized with polyethylene glycol (PEG) were synthetized and
administered to rabbits to evaluate its use in clinical practice as
theranostic agent for atherosclerosis. This was done by measuring the
porphyrin ﬂuorescence extracted for the rabbit's blood and feces. An
increase in the blood and feces porphyrin emission after ALA:AuNPs
administration suggests that ALA was incorporated by the gold
nanoparticles, its structure was preserved, and a rapid conversion into
endogenous porphyrins occurred, overloading the synthetic pathway
that lead to the PPIX accumulation. Results: The results show that the
functionalized gold nanoparticles reached atheromatous plaques and its
ALA was converted to PPIX. The selective accumulation of PPIX in
plaques provides a contrast between control animals and those with
atherosclerosis. Conclusions: An increase in the blood and feces
porphyrin emission after ALA:AuNPs administration suggests that ALA
was incorporated by the gold nanoparticles, its structure was preserved,
and a rapid conversion into endogenous porphyrins occurred, over-
loading the synthetic pathway that lead to the PPIX accumulation. The
high accumulation of PPIX in tissues is thought to be the result of
uncontrolled cell proliferation that accompanied the growth of athero-
matous plaques. This ﬁnding indicated that ALA:AuNPs can aid in the
early diagnosis and therapy of atherosclerosis with high sensitivity.
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Introduction: Low HDL-cholesterol (hypoalphalipoproteinemia)
is considered an independent risk factor for atherosclerosis. This
inverse relationship has been attributed to different protective
properties, such as cholesterol efﬂux, inhibition of platelet aggrega-
tion, and their antioxidant and anti-inﬂammatory activities. Thus, we
explored the association between functions of HDL in patients free of
cardiovascular disease and hypoalphalipoproteinemia or atheroscle-
rotic burden. Methods: Study participants were classiﬁed according
to their plasma HDL-cholesterol levels: below the 10th percentile, a
group with low HDL-C (LH; ≤32 mg/dL; n = 33), between percen-
tiles 40 and 60, intermediate group (IH; 40–67 mg/d; n = 33) or
above the 90th percentile, a group with high levels of HDL-C (HH;
≥78 mg/d; n = 35). The chemical composition of HDL, particle size,
cholesterol efﬂux capacity, antioxidant activity, susceptibility to
oxidation, anti-inﬂammatory activity and ability to inhibit platelet
aggregation were measured in 101 patients. Intima–media thickness
of the carotid arteries (CIMT) was determined by high-resolution
ultrasonography. Results: The LH group was associated with
increased CIMT (0.72 ± 0.3 vs. 0.61 ± 0.20 in IH and 0.65 ± 0.15 in
HH; p ≤ 0,001), increased HDL-triglyceride (4 ± 2% vs. 4 ± 2% in IH
and 3 ± 1% in HH, p ≤ 0.001), reduced HDL-phospholipid (12 ± 4%
vs 14 ± 5% in IH and 13 ± 3% HH, p = 0.035), reduced size of HDL
particle (7.33 ± 0.33 nm vs. 7.72 ± 0.45 nm in IH, and 8.49 ±
0.42 nm in HH, p ≤ 0.001), and reduced cholesterol efﬂux capacity
(9 ± 3% vs. 12 ± 3% in IH and 11 ± 4% in HH, p ≤ 0.001).
CIMT N 1 mm was associated with reduced HDL size (7.55 ±
0.49 nm vs. 7.89 ± 0.64 nm, p ≤ 0.001), antioxidant activity (37
(23)% vs 49 (42)%, p = 0.018), and reduced cholesterol efﬂux
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